ITM and Grand Pharma Enter into a Commercialization Agreement for Targeted Radiopharmaceuticals in the Greater China Area
Grand Pharma has licensed the development, manufacturing and commercialization rights of ITM’s Targeted Radionuclide Therapeutic…